keyword
https://read.qxmd.com/read/38717686/efficacy-and-survival-of-nivolumab-treatment-for-recurrent-unresectable-esophageal-squamous-cell-carcinoma-real-world-clinical-data-from-a-large-multi-institutional-cohort
#21
JOURNAL ARTICLE
Tomoki Makino, Shigeto Nakai, Kota Momose, Kotaro Yamashita, Koji Tanaka, Hiroshi Miyata, Sachiko Yamamoto, Masaaki Motoori, Yutaka Kimura, Yuki Ushimaru, Motohiro Hirao, Jin Matsuyama, Yusuke Akamaru, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki
BACKGROUND: Real-world clinical outcomes of and prognostic factors for nivolumab treatment for esophageal squamous-cell carcinoma (ESCC) remain unclear. This study aimed to evaluate real-world outcomes of nivolumab monotherapy in association with relevant clinical parameters in recurrent/unresectable advanced ESCC patients. METHODS: This population-based multicenter cohort study included a total of 282 patients from 15 institutions with recurrent/unresectable advanced ESCC who received nivolumab as a second-line or later therapy between 2014 and 2022...
May 8, 2024: Esophagus: Official Journal of the Japan Esophageal Society
https://read.qxmd.com/read/38717538/insights-into-systemic-lupus-erythematosus-a-retrospective-observational-study-of-clinical-features-autoantibodies-and-gender-related-differences
#22
JOURNAL ARTICLE
Marwan H Adwan, Ula Qasem, Saed Y Atawnah, Muath Itmeizeh, Rifaat Hanbali, Najla Ali Alsoofi, Mohammed Abu Jbara, Ayman AbuHelal, Fatima Alnaimat
This study aims to analyze the clinical and immunologic features of SLE in Jordan, while also investigating the impact of age and gender on disease presentation. The study included 275 patients diagnosed with SLE. Data were collected through meticulous patient interviews and thorough examination of patient hospital records. The cohort exhibited a mean age of 36.8 ± 12.9 years, with an average disease duration of 7.0 ± 7.8 years. The mean age at diagnosis was 29...
May 8, 2024: Rheumatology International
https://read.qxmd.com/read/38717066/unveiling-actin-cytoskeleton-role-in-mediating-chikungunya-associated-arthritis-an-integrative-proteome-metabolome-study
#23
JOURNAL ARTICLE
Althaf Mahin, Sourav Chikmagalur Ravindra, Poornima Ramesh, Prashantha Naik, Rajesh Raju, Thottethodi Subrahmanya Keshava Prasad, Chandran S Abhinanad
Background: Chikungunya is a zoonotic disease caused by the Chikungunya virus (CHIKV), primarily transmitted to humans through infected Aedes mosquitoes. The infection is characterized by symptoms such as high fever, musculoskeletal pain, polyarthritis, and a rash, which can lead to severe complications such as encephalitis, meningitis, and even fatalities. While many disease manifestations resemble those of other viral infections, chronic arthritis caused by CHIKV is unique, and its molecular mechanisms remain ill-defined...
May 7, 2024: Vector Borne and Zoonotic Diseases
https://read.qxmd.com/read/38716496/suspected-cutaneous-allergic-reactions-with-ayurveda-medicine-punaranava-mandura-a-case-report
#24
Suhitha Roseleena, Poonam Kholiya, N Chandan, Manish Barvaliya, Chandrashekhar Siddapur, Subarna Roy
INTRODUCTION: With the increasing use of traditional medicine, there is a need to be vigilant in identifying and reporting adverse reactions associated with them. Punarnava Mandura is a commonly used Ayurvedic medicine for the treatment of anemia. It is well tolerated by the patients. To our knowledge, allergic reactions to Punarnava Mandura have not been reported in the literature. We reported a case of adverse cutaneous reaction, which was probably associated with Purnarnava Mandura...
April 22, 2024: Current Drug Safety
https://read.qxmd.com/read/38716013/hyperinsulinemic-state-and-hypokalemic-quadriparesis-in-tropical-fever-is-there-a-link
#25
Amitabha Saha, Arjun Talapatra, Sushmita Basu, Souvik Sarkar, Sourav Sarkar
It is rare for quadriparesis to manifest as a symptom of tropical illnesses. With a history of only one fever episode one week prior, our patient, a 48-year-old male with obesity and prediabetes, who was also known to have ankylosing spondylitis, presented with acute onset flaccid quadriparesis. He did not exhibit any additional symptoms of dengue, such as bleeding tendencies, petechial rashes, thrombocytopenia, or febrile episodes. Upon examination, it was discovered that he had extremely low serum potassium levels and was dengue non-specific antigen 1 (NS1) positive...
April 2024: Curēus
https://read.qxmd.com/read/38716007/silent-storm-unveiled-lupus-nephritis-and-cerebral-vasculitis-in-systemic-lupus-erythematosus
#26
Rucha Sawant, Shilpa A Gaidhane, Vrushali Mahajan, Pranav Chaudhari, Gautam N Bedi
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder known for its intricate clinical manifestations, spanning a spectrum of symptoms, including neuropsychiatric SLE (NPSLE) and lupus nephritis (LN). This condition predominantly affects young women of childbearing age, presenting a diverse array of symptoms that pose challenges in both diagnosis and treatment. Diagnosing central nervous system (CNS) involvement in SLE remains notably difficult despite being rooted in an autoimmune inflammatory response driven by cytokine surges...
April 2024: Curēus
https://read.qxmd.com/read/38715486/-clinical-analysis-of-cytomegalovirus-infection-associated-hemophagocytic-lymphohistiocytosis-in-five-patients-without-underlying-diseases
#27
JOURNAL ARTICLE
X Y Zhang, T L Qiu, H J Huang, H Y Zhu, J Y Li, W Y Shi, Y Miao
The clinical data of five patients [one male and four female; median age: 31 (21-65) years] with cytomegalovirus (CMV)-induced hemophagocytic lymphohistiocytosis (HLH) diagnosed and treated in the First Affiliated Hospital of Nanjing Medical University were retrospectively analyzed from January 2011 to December 2020. None of the patients had any underlying disease, and all were immunocompetent. The main clinical presentations were fever in all five patients, splenomegaly in four, enlarged lymph nodes in two, liver enlargement in one, and rash in three...
May 1, 2024: Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]
https://read.qxmd.com/read/38714072/the-case-of-mediterranean-spotted-fever-of-the-traveler-returned-from-zambia
#28
JOURNAL ARTICLE
Takahiro Ichikawa, Yongjin Qiu, Shuji Ando, Yuto Takeuchi, Atsushi Nagasaka
We report the case of a traveler who returned from Zambia and was diagnosed with Mediterranean spotted fever (MSF), an infectious disease caused by Rickettsia conorii conorii. The patient presented to Sapporo City General Hospital with symptoms of fever, malaise, headache, and rash. The pathogen was identified by Polymerase Chain Reaction assays and subsequent analyses. The patient improved with 10-day treatment of oral doxycycline. Although some cases of MSF have been reported in sub-Saharan Africa, none have been reported in Zambia...
May 6, 2024: Ticks and Tick-borne Diseases
https://read.qxmd.com/read/38714036/activated-carbon-and-their-nanocomposites-derived-from-vegetable-and-fruit-residues-for-water-treatment
#29
JOURNAL ARTICLE
A A Thamer, A Mustafa, H Q Bashar, Bao Van, Phuoc-Cuong Le, Miklós Jakab, T R Rashed, Karol Kułacz, MustafaM Hathal, Viola Somogyi, D Duc Nguyen
Water pollution remains a pressing environmental issue, with diverse pollutants such as heavy metals, pharmaceuticals, dyes, and aromatic hydrocarbon compounds posing a significant threat to clean water access. Historically, biomass-derived activated carbons (ACs) have served as effective adsorbents for water treatment, owing to their inherent porosity and expansive surface area. Nanocomposites have emerged as a means to enhance the absorption properties of ACs, surpassing conventional AC performance. Biomass-based activated carbon nanocomposites (ACNCs) hold promise due to their high surface area and cost-effectiveness...
May 6, 2024: Journal of Environmental Management
https://read.qxmd.com/read/38712673/safety-and-tolerability-of-amg-330-in-adults-with-relapsed-refractory-aml-a-phase-1a-dose-escalation-study
#30
JOURNAL ARTICLE
Farhad Ravandi, Marion Subklewe, Roland B Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
AMG 330, a bispecific T-cell engager (BiTE®) that binds CD33 and CD3 on T cells facilitates T-cell-mediated cytotoxicity against CD33+ cells. This first-in-human, open-label, dose-escalation study evaluated the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of AMG 330 in adults with relapsed/refractory acute myeloid leukemia (R/R AML). Amongst 77 patients treated with AMG 330 (0.5 µg/day-1.6 mg/day) on 14-day or 28-day cycles, maximum tolerated dose was not reached; median duration of treatment was 29 days...
May 7, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38712133/phase-2-study-of-sorafenib-valproic-acid-and-sildenafil-in-the-treatment-of-recurrent-high-grade-glioma
#31
Andrew S Poklepovic, Palak Shah, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Xiaoyan Deng, Catherine H Roberts, Alison A Ryan, Daniel Hudson, Heidi Sankala, Maciej Kmieciak, Paul Dent, Mark G Malkin
Here we report the results of a single-center phase 2 clinical trial combining sorafenib tosylate, valproic acid, and sildenafil for the treatment of patients with recurrent high-grade glioma ( NCT01817751 ). Clinical toxicities were grade 1 and grade 2, with one grade 3 toxicity for maculopapular rash (6.4%). For all evaluable patients, the median progression-free survival was 3.65 months and overall survival (OS) 10.0 months. There was promising evidence showing clinical activity and benefit. In the 33 evaluable patients, low protein levels of the chaperone GRP78 (HSPA5) was significantly associated with a better OS (p < 0...
April 24, 2024: medRxiv
https://read.qxmd.com/read/38711889/effective-treatment-of-met-exon-14-skipping-mutation-positive-non-small-cell-lung-cancer-using-capmatinib-following-serious-maculopapular-rash-caused-by-two-met-inhibitors-a-case-report
#32
Fumihiro Kashizaki, Shunsuke Okazaki, Nanami Tsuchiya, Hao Chen, Harumi Koizumi, Kenichi Takahashi
BACKGROUND: Multi-gene panel testing and advancements in molecular targeted therapy have improved the overall survival of patients with driver mutation-positive non-small cell lung cancer (NSCLC). Mesenchymal-epithelial transition factor ( MET ) exon 14 skipping mutation-positive NSCLC, which remains untreated with MET inhibitors, shows a poorer prognosis than do cases of NSCLC without MET mutations. However, serious treatment-related adverse events (TRAEs) act as substantial treatment barriers...
2024: AME Case Reports
https://read.qxmd.com/read/38711856/double-dose-osimertinib-combined-with-intrathecal-injection-of-pemetrexed-improves-the-efficacy-of-egfr-mutant-non-small-cell-lung-cancer-and-leptomeningeal-metastasis-case-report-and-literature-review
#33
Wenjuan Zhong, Longqiu Wu, Lixing Huang, Jianfeng Wang, Huaqiu Shi, Shugui Wu
Leptomeningeal metastasis (LM) is a complication of non-small cell lung cancer (NSCLC) characterized by poor prognosis and short survival. A variety of therapeutic approaches have been sought to improve the efficacy of LM. Here we present a clinical case and conduct a literature review to investigate the effectiveness and safety of double-dose osimertinib combined with a pemetrexed intrathecal injection. This is an older man who underwent thoracoscopic pneumonectomy and was diagnosed with stage IIA lung adenocarcinoma with EGFR21 L858R mutation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38711841/dress-syndrome-without-eosinophilia-presented-with-extensive-skin-rash-and-acute-respiratory-failure
#34
Nattanicha Chaisrimaneepan, Corley Pruneda, Marwan Elmassry, Mahmoud Abdelnabi
This case demonstrated the complex pathophysiology of DRESS syndrome presenting with latent human herpes virus infection reactivation due to exposure to sulfasalazine and/or hydroxychloroquine. Patients who do not initially fulfill the diagnostic criteria on admission may evolve and eventually fulfill the criteria. Steroid dose tapering is required to prevent flaring.
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38711701/unraveling-the-diagnosis-of-hypocomplementemic-urticarial-vasculitis-syndrome
#35
Syed Bukhari, Mohamed Ghoweba, Syed Khan, Geoffrey Ouma
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare condition characterized by immune complex-mediated urticarial lesions with histological features of leukocytoclastic vasculitis, low serum complement levels, and is frequently associated with systemic manifestations. Its pathophysiology is poorly understood. We present a patient who presented with abdominal pain and skin rash. Extensive work-up was performed including skin biopsy, and the presence of angioedema, oral ulcers, low complement level, leukocytic vasculitis, and persistent eosinophilia ultimately led to the diagnosis of HUVS...
April 2024: Curēus
https://read.qxmd.com/read/38711695/urticarial-vasculitis-induced-by-adalimumab-biosimilar-in-an-elderly-female-with-hidradenitis-suppurativa-a-case-report
#36
Miasser Alarnaouti, Sultan Alfaer, Mawaddah Tallab, Asmaa A Khojah, Talah Magadmi, Abdulaziz Kadasa, Maha A Binsaqr
Urticarial vasculitis (UV) is a type of small-vessel vasculitis, which is rarely associated with anti-tumor necrosis factor (TNF)-alpha medication. We describe a 72-year-old woman with multiple comorbidities on several medications, including an adalimumab biosimilar for Hurley stage II recalcitrant hidradenitis suppurativa (HS), who presented with new-onset severe angioedema and a rash with urticarial wheals that covered most of her body surface area. The diagnosis of drug-induced UV is supported by both the history of adalimumab biosimilar use and the histopathology result...
April 2024: Curēus
https://read.qxmd.com/read/38711014/disseminated-talaromyces-marneffei-infection-initially-presenting-as-cutaneous-and-subcutaneous-lesion-in-an-hiv-negative-renal-transplant-recipient-a-case-report-and-literature-review
#37
REVIEW
Shanshan Yang, Lixin Lou, Shuhong Ma, Haoliang Wang, Lanxiang Rong, Ying Liu, Kaiyu Zhang, Qing Ai, Xu Shi
BACKGROUND: The incidence of Talaromyces marneffei (T. marneffei) infection has increased in recent years with the development of organ transplantation and the widespread use of immunosuppressive agents. However, the lack of clinical suspicion leading to delay or misdiagnosis is an important reason for the high mortality rate in non-human immunodeficiency virus (HIV) and non-endemic population. Herein, we report a case of disseminated T. marneffei infection in a non-HIV and non-endemic recipient after renal transplant, who initially presented with skin rashes and subcutaneous nodules and developed gastrointestinal bleeding...
May 6, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38709693/beyond-the-label-real-world-side-effects-experienced-with-fda-approved-drugs-for-non-melanoma-skin-cancers
#38
JOURNAL ARTICLE
Advaitaa Ravipati, Tejus Pradeep, Keyvan Nouri
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). The immune checkpoint inhibitors approved by the FDA target programmed cell death protein 1 (PD-1) and the Hedgehog (Hh) signaling pathway. These medications have expanded treatment options; however, side effects are an important consideration. We used the FDA Adverse Events Reporting System (FAERS) to characterize the most prevalent, real-world side effects experienced by patients on these agents...
May 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38709355/pharmaceutical-equivalent-5-aminolevulinic-acid-fluorescence-guided-resection-of-central-nervous-system-tumors-feasibility-safeness-and-cost-benefit-considerations
#39
JOURNAL ARTICLE
Erasmo Barros da Silva, Ricardo Ramina, Jorge Luis Novak Filho, Gustavo Simiano Jung, Giulia Xavier Bornancin, Maurício Coelho Neto
PURPOSE: 5-aminolevulinic acid (5-ALA) fluorescence-guided resection (FGR) has been an essential tool in the 'standard of care' of malignant gliomas. Over the last two decades, its indications have been extended to other neoplasms, such as metastases and meningiomas. However, its availability and cost-benefit still pose a challenge for widespread use. The present article reports a retrospective series of 707 cases of central nervous system (CNS) tumors submitted to FGR with pharmacological equivalent 5-ALA and discusses financial implications, feasibility and safeness...
May 6, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38708024/clinical-phenotyping-in-patients-with-anti-synthetase-antibodies-using-cluster-analysis
#40
JOURNAL ARTICLE
Shintaro Yamamoto, Akira Yoshida, Yuka Okazaki, Takahisa Gono, Masataka Kuwana
OBJECTIVES: To characterize clinically distinct subgroups among unselected patients with anti-synthetase antibodies using cluster analysis. METHODS: This study evaluated patients with anti-synthetase antibodies registered to two independent cohorts; 106 consecutive patients from a prospective, single-centre cohort of the Scleroderma/Myositis Centre of Excellence (SMCE) were used as a derivation cohort and 125 patients from the Multicentre Retrospective Cohort of Japanese Patients with Myositis-Associated Interstitial Lung Disease (JAMI) were used as a validation cohort...
2024: Rheumatology Advances in Practice
keyword
keyword
3946
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.